1-3 of 3
Barbara A. Hutten
Close
Sort by
Journal Articles

Effect of Brentuximab Vedotin Addition to Chemotherapy and Prognostic Factors in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Large Multi-Trial Analysis Based on Individual Patient Data

Julia Driessen, Fer de Wit, Alex F. Herrera, Pier Luigi Luigi Zinzani, Ann S. LaCasce, Craig H. Moskowitz, Ramon Garcia-Sanz, Peter D. Cole, Michael Fuchs, Horst Mueller, Peter Borchmann, Heiko Schöder, Josée M Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten
Journal: Blood
Blood (2021) 138 (Supplement 1): 879.
https://doi.org/10.1182/blood-2021-147810
Published: 2021
Journal Articles

Circulating Nucleosomes and Neutrophil Activation As Risk Factors for Deep Vein Thrombosis

Maurits L van Montfoort, MD, Femke Stephan, Mandy N Lauw, MD, Barbara A Hutten, PhD, Gerard J van Mierlo, Shabnam Solati, Saskia Middeldorp, MD, PhD, Joost CM Meijers, PhD, Sacha S Zeerleder, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3387.
https://doi.org/10.1182/blood.V120.21.3387.3387
Published: 2012
Journal Articles

Aspirin and Aspirin Combined with Low-Molecular-Weight Heparin in Women with Unexplained Recurrent Miscarriage: a Randomized Controlled Multicenter Trial (ALIFE Study).

Stef P. Kaandorp, MD, Mariëtte Goddijn, MD, PhD, Joris A.M. van der Post, MD, PhD, Barbara A. Hutten, PhD, Harold R. Verhoeve, MD, Karly Hamulyak, MD, PhD, Ben-Willem Mol, MD, PhD, Nienke Folkeringa, MD, PhD, Marleen Nahuis, MD, Dimitri Papatsonis, MD, PhD, Harry R. Buller, MD, PhD, Fulco van der Veen, MD, PhD, Saskia Middeldorp, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 488.
https://doi.org/10.1182/blood.V114.22.488.488
Published: 2009